BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29719685)

  • 1. Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes.
    Poreba M; Rut W; Vizovisek M; Groborz K; Kasperkiewicz P; Finlay D; Vuori K; Turk D; Turk B; Salvesen GS; Drag M
    Chem Sci; 2018 Feb; 9(8):2113-2129. PubMed ID: 29719685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples.
    Poreba M; Groborz K; Vizovisek M; Maruggi M; Turk D; Turk B; Powis G; Drag M; Salvesen GS
    Chem Sci; 2019 Sep; 10(36):8461-8477. PubMed ID: 31803426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.
    Bogyo M; Verhelst S; Bellingard-Dubouchaud V; Toba S; Greenbaum D
    Chem Biol; 2000 Jan; 7(1):27-38. PubMed ID: 10662686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clickable, selective, and cell-permeable activity-based probe of human cathepsin B - Minimalistic approach for enhanced selectivity.
    Bhuiyan AI; Rathod P; Ghoshal S; Dana D; Das T; Li G; Dickson AA; Rafi F; Subramaniam GS; Fath KR; Paroly S; Chang EJ; Pathak SK
    Bioorg Chem; 2021 Dec; 117():105463. PubMed ID: 34753058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine cathepsins L and X differentially modulate interactions between myeloid-derived suppressor cells and tumor cells.
    Jakoš T; Pišlar A; Pečar Fonović U; Švajger U; Kos J
    Cancer Immunol Immunother; 2020 Sep; 69(9):1869-1880. PubMed ID: 32372139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.
    Edgington-Mitchell LE; Rautela J; Duivenvoorden HM; Jayatilleke KM; van der Linden WA; Verdoes M; Bogyo M; Parker BS
    Oncotarget; 2015 Sep; 6(29):27008-22. PubMed ID: 26308073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
    Jung M; Lee J; Seo HY; Lim JS; Kim EK
    PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages.
    Lah TT; Hawley M; Rock KL; Goldberg AL
    FEBS Lett; 1995 Apr; 363(1-2):85-9. PubMed ID: 7729559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L.
    Banati RB; Rothe G; Valet G; Kreutzberg GW
    Glia; 1993 Feb; 7(2):183-91. PubMed ID: 8432559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions.
    Jordans S; Jenko-Kokalj S; Kühl NM; Tedelind S; Sendt W; Brömme D; Turk D; Brix K
    BMC Biochem; 2009 Sep; 10():23. PubMed ID: 19772638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of cathepsin S detection using a designed FRET peptide based on putative natural substrates.
    Oliveira M; Torquato RJ; Alves MF; Juliano MA; Brömme D; Barros NM; Carmona AK
    Peptides; 2010 Apr; 31(4):562-7. PubMed ID: 20045715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
    Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
    Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gamma.
    Schwarz G; Boehncke WH; Braun M; Schröter CJ; Burster T; Flad T; Dressel D; Weber E; Schmid H; Kalbacher H
    J Invest Dermatol; 2002 Jul; 119(1):44-9. PubMed ID: 12164923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Cleavage Properties of Cathepsin B Compared to Cysteine Cathepsins Enable the Design and Validation of a Specific Substrate for Cathepsin B over a Broad pH Range.
    Yoon MC; Phan V; Podvin S; Mosier C; O'Donoghue AJ; Hook V
    Biochemistry; 2023 Aug; 62(15):2289-2300. PubMed ID: 37459182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel photoaffinity-based probe for selective detection of cathepsin L active form.
    Torkar A; Bregant S; Devel L; Novinec M; Lenarčič B; Lah T; Dive V
    Chembiochem; 2012 Nov; 13(17):2616-21. PubMed ID: 23125066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines.
    Špes A; Sobotic B; Turk V; Turk B
    Biol Chem; 2012 Dec; 393(12):1417-31. PubMed ID: 23667901
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.